Patent · US Active

Nicotinamide-based kinase inhibitors

US8030336B2 · kind B2 · utility

18Cited by

1References

6Claims

0Family size

Assignee

YM BIOSCIENCES AUSTRALIA PTY LTD. · AU

Inventors

Christopher J. Burns · Vivonne Bay, AU
Marcel Robert Kling · Melbourne, AU

Key dates

Filing date	Dec 15, 2003
Grant date	Oct 4, 2011
Priority date	—
Expiry date	Jun 20, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of the general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof is described. A method of treating tyrosine kinase-associated disease states in a subject using a compound of formula (I) is also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.